Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.46
+0.42 (6.95%)
At close: Jun 24, 2026, 4:00 PM EDT
6.45
-0.01 (-0.15%)
After-hours: Jun 24, 2026, 4:42 PM EDT

Nuvation Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,2493,1058993314201,853
Market Cap Growth
166.56%245.48%171.69%-21.20%-77.34%6.24%
Enterprise Value
1,9592,779404.87-276.45-236.981,090
Last Close Price
6.468.962.661.511.928.50
PS Ratio
15.9149.36114.14---
PB Ratio
6.57-2.78-0.99-0.97-1.54-11.30
EV/Sales Ratio
13.6944.1751.43---
EV/EBITDA Ratio
---2.781.98-
EV/EBIT Ratio
---2.771.98-
EV/FCF Ratio
---4.062.46-
Debt / Equity Ratio
0.650.660.020.000.000.00
Net Debt / Equity Ratio
0.290.290.541.772.414.65
Net Debt / EBITDA Ratio
2.191.540.836.105.498.19
Net Debt / FCF Ratio
2.581.883.788.926.8111.13
Asset Turnover
0.240.110.01000
Inventory Turnover
0.881.63----
Quick Ratio
7.046.678.9144.0050.4145.40
Current Ratio
7.446.959.0444.1150.7045.62
Return on Equity (ROE)
-46.70%-53.18%-106.27%-12.03%-14.87%-18.07%
Return on Assets (ROA)
-24.92%-37.53%-101.99%-15.43%-16.53%-18.70%
Return on Invested Capital (ROIC)
-320.19%-505.45%-2929.74%-1529.72%-2182.94%-3084.89%
Return on Capital Employed (ROCE)
-28.79%-42.83%-108.75%-15.76%-16.89%-19.15%
Buyback Yield / Dilution
-15.09%-27.07%-22.79%-1.00%-9.52%-102.90%
Total Shareholder Return
-15.09%-27.07%-22.79%-1.00%-9.52%-102.90%
SEC Filings: 10-K · 10-Q